LUCD - Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript

2025-08-13 16:39:11 ET

Lucid Diagnostics Inc. (LUCD)

Q2 2025 Earnings Call

August 13, 2025 08:30 A.M. ET

Company Participants

Dennis M. McGrath - Chief Financial Officer

Lishan Aklog - Chairman & CEO

Matthew Riley - Director of Investor Relations

Conference Call Participants

Anthony V. Vendetti - Maxim Group LLC, Research Division

Edward Moon Woo - Ascendiant Capital Markets LLC, Research Division

Mark Anthony Massaro - BTIG, LLC, Research Division

Michael Stephen Matson - Needham & Company, LLC, Research Division

Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division

Presentation

Operator

Good morning, and welcome to the Lucid Diagnostics Second Quarter 2025 Business Update Conference Call. [Operator Instructions]

Please note that this event is being recorded. I would now like to turn the conference over to Matt Riley, Lucid Diagnostics Senior Director of Investor Relations.

Matthew Riley

Thank you, operator, and good morning, everyone, and thank you for participating in today's business update call.

Joining me today on the call are Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer....

For further details see: